EU ingredient rules · 1 min read

Hydrogenated Tallowamine in cosmetics: EU rules

Quick answer: Hydrogenated Tallowamine is a restricted cosmetic ingredient in the EU: Annex III (entry 61) allows it only within set limits. CosIng lists its functions as antistatic, emulsifier, light stabilizer and cleansing surfactant.

Key facts

Hydrogenated Tallowamine at a glance
INCI nameHYDROGENATED TALLOWAMINE
CAS number61788-45-2
EC number262-976-6
EU statusRestricted (Annex III, entry 61)
Functions (CosIng)Antistatic, Emulsifier, Light stabilizer, Cleansing surfactant, Viscosity controlling

CosIng description: Amines, hydrogenated tallow alkyl

What it does in a product

  • Antistatic: Reduces static electricity, so hair is less flyaway.
  • Emulsifier: Lets oil and water blend into a cream or lotion.
  • Light stabilizer: Protects the formula itself from being broken down by light.
  • Cleansing surfactant: Washes away dirt and oil.
  • Viscosity controlling: Thickens or thins a product.

Annex III: restricted substances, entry 61

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Monoalkylamines, monoalkanolamines and their salts

Maximum concentration in the ready-to-use product:

Other conditions:

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2009/1223.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for HYDROGENATED TALLOWAMINE and Annex III/61, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.